Moderna is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at what to expect in ...

Pharma giant Moderna (MRNA) is set to release its Q4 2024 results on February 14. MRNA stock has lost about 64% over the past ...

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

We recently compiled a list of the 10 Firms Fall Amid Disappointing Earnings Performance. In this article, we are going to ...

It has been almost five years since the COVID-19 pandemic happened and close to two years since President Marcos lifted the public health emergency in the country. And yet, costly irregularities, ...

Shares of vaccine makers and packaged food companies fell on Tuesday after President Donald Trump's pick for U.S. health ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ ... visibility into the sales trajectory of its respiratory vaccine business. Moderna (NASDAQ:MRNA) earlier projected ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ ... company has limited visibility into the sales trajectory of its respiratory vaccine business. Moderna (NASDAQ:MRNA) ...

In these cases, the label on the vaccine vial had also been falsified. The Vaccine Identify Evaluation (VIE) Collaboration are developing novel tests for detecting falsified vaccines in supply chains.